Millbrae, CA, United States of America

Suchismita Mohanty

This inventor holds 1 USPTO granted patent and 4 published patent applications. Top assignee: William Robert Arathoon Living Trust Dated August 29, 2016. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Suchismita Mohanty. Retrieved from https://idiyas.com/inventor/suchismita-mohanty

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 8.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Suchismita Mohanty: Innovator in Cancer Treatment

Introduction

Suchismita Mohanty is a notable inventor based in Millbrae, CA (US). He has made significant contributions to the field of cancer treatment through his innovative research and development of multi-specific antibodies.

Latest Patents

Suchismita Mohanty holds a patent for "Efflux pump-cancer antigen multi-specific antibodies and compositions, reagents, kits and methods related thereto." This patent provides multi-specific antibodies that target both a cellular efflux pump and a cancer-associated antigen. The invention includes pharmaceutical compositions, nucleic acids, recombinant expression vectors, cells, and kits that incorporate or encode these multi-specific antibodies. Additionally, the patent outlines methods for treating cancer by administering these antibodies to subjects, as well as methods for generating the described antibodies and related reagents.

Career Highlights

Suchismita Mohanty is associated with the William Robert Arathoon Living Trust Dated August 29, 2016. His work focuses on advancing cancer treatment methodologies through innovative antibody development.

Collaborations

Some of his coworkers include William Robert Arathoon and Evan Matthew Bishop. Their collaborative efforts contribute to the ongoing research and development in the field of cancer therapeutics.

Conclusion

Suchismita Mohanty's work in developing multi-specific antibodies represents a significant advancement in cancer treatment. His innovative approach has the potential to improve therapeutic outcomes for patients battling cancer.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…